Remote Jobs at Replimune

Replimune

201 - 500 employees

Founded 2015

🧬 Biotechnology

🏥 Healthcare

💊 Pharmaceuticals

💰 $140M Post-IPO Equity - Replimune Group on 2024-11

Biotechnology • Healthcare • Pharmaceuticals

Replimune is a clinical-stage biotechnology company focused on developing a new class of oncolytic immunotherapies intended to activate powerful, durable systemic anti-tumor immune responses. The company’s approach is to kill tumors locally, alter the tumor microenvironment, and ignite a full-body, tumor-specific immune response. Replimune is conducting clinical programs evaluating the safety and effectiveness of its investigational therapies in a range of solid tumors, both as single agents and in combination with other immunotherapies.